<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Title 21 CFR Part 11 / United States federal law / Government / Electronic signature / Federal Register / Ood / Audit / Medicine / United States administrative law / Pharmaceutical industry / Food and Drug Administration
Date: 2004-04-26 10:50:50
Pharmaceuticals policy
Title 21 CFR Part 11
United States federal law
Government
Electronic signature
Federal Register
Ood
Audit
Medicine
United States administrative law
Pharmaceutical industry
Food and Drug Administration

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 108,32 KB

Share Document on Facebook

Similar Documents

Court Connection Volume No. 7 – Issue No. 2 April 2018 Dear Point and Click, I have some questions about signature requirements for the Court’s electronic filing (CM/ECF) System.

DocID: 1u9uv - View Document

APPLICATION TO ESTABLISH CONTRACTOR ELECTRONIC WIRING CERTIFICATE (E-CERT) ACCOUNT, ELECTRONIC SIGNATURE, AND INTERNET ACCESS TO e-CERT SYSTEM Contractor electronic wiring certificate (e-Cert) accounts are established fo

DocID: 1tZR6 - View Document

Promoting confi dence in electronic commerce: legal issues on international use of electronic authentication and signature methods

DocID: 1tV2t - View Document

Notice of Development of Rulemaking DEPARTMENT OF STATE Division of Corporations RULE NO.: RULE TITLE: 1N-5.002: Notary’s Electronic Signature

DocID: 1rVyY - View Document

Security / Prevention / Cryptography / Computer law / Signature / E-commerce / EIDAS / Internet of things / Internet privacy / Electronic signature / Privacy / Computer security

EEMA online January 2016 Issue 1 Diary dates 2016 Below are some of the events that we are holding next year. Be sure to bookmark them now! For further information visit www.eema.org/events.

DocID: 1rp1i - View Document